The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Shares of WW International Inc., the company known as WeightWatchers, pared back their early gains Monday despite better-than ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...

Accusing doctors of “dishing out” medications for weight loss and then labelling people “cheats” for using them is a ...